What was the market valuation of the North America graphene market in 2024?

The market valuation was $72.0 Million in 2024. Read More

What is the projected market valuation for the North America graphene market by 2035?

The projected valuation for 2035 is $900.07 Million. Read More

What is the expected CAGR for the North America graphene market during the forecast period 2025 - 2035?

The expected CAGR is 25.81% during the forecast period 2025 - 2035. Read More

Which application segment had the highest valuation in 2024?

The Composites application segment had the highest valuation at $250.0 Million in 2024. Read More

What are the key players in the North America graphene market?

Key players include Graphenea, First Graphene, Haydale Graphene Industries, and XG Sciences. Read More

Which type of graphene is projected to have the highest valuation by 2035?

Graphene Nanoplatelets is projected to have the highest valuation at $300.0 Million by 2035. Read More

What was the valuation of the Energy Storage segment in 2024?

The Energy Storage segment was valued at $200.0 Million in 2024. Read More

How does the Healthcare end-use industry segment perform in terms of valuation?

The Healthcare end-use industry segment had a valuation of $250.0 Million in 2024. Read More

What form of graphene is expected to show significant growth by 2035?

The Dispersions form is expected to show significant growth, with a projected valuation of $350.07 Million by 2035. Read More

What does the market data suggest about the future of the North America graphene market?

The data suggests robust growth, with a projected increase in valuation from $72.0 Million in 2024 to $900.07 Million by 2035. Read More

North America Graphene Market

ID: MRFR/CnM/45613-HCR

111 Pages

Chitranshi Jaiswal

Last Updated: April 06, 2026

North America Graphene Market Research Report By Type (Graphene Oxide (GO), Graphene Nanoplatelets (GNP), Few Layer Graphene (FLG), Mono-Layer & Bi-Layer Graphene, Others), By End User (Automotive, Aerospace, Pharmaceutical, Energy, Coatings, Electronics, Chemical, Others) and By Regional (US, Canada)- Forecast to 2035

North America Graphene Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Electronics
  2. 4.1.2 Energy Storage
  3. 4.1.3 Composites
  4. 4.1.4 Coatings
  5. 4.1.5 Biomedicine
2. 4.2 Pharmaceutical, BY Type (USD Million)
  1. 4.2.1 Graphene Oxide
  2. 4.2.2 Reduced Graphene Oxide
  3. 4.2.3 Graphene Nanoplatelets
  4. 4.2.4 Monolayer Graphene
3. 4.3 Pharmaceutical, BY End Use Industry (USD Million)
  1. 4.3.1 Consumer Electronics
  2. 4.3.2 Automotive
  3. 4.3.3 Aerospace
  4. 4.3.4 Healthcare
  5. 4.3.5 Construction
4. 4.4 Pharmaceutical, BY Form (USD Million)
  1. 4.4.1 Powder
  2. 4.4.2 Suspension
  3. 4.4.3 Film
  4. 4.4.4 Dispersions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Graphenea (ES)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 First Graphene (AU)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Haydale Graphene Industries (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Applied Graphene Materials (GB)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 XG Sciences (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 NanoXplore (CA)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Directa Plus (IT)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Graphene Flagship (EU)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS BY APPLICATION
3. 6.3 NORTH AMERICA MARKET ANALYSIS BY TYPE
4. 6.4 NORTH AMERICA MARKET ANALYSIS BY END USE INDUSTRY
5. 6.5 NORTH AMERICA MARKET ANALYSIS BY FORM
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY END USE INDUSTRY, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY END USE INDUSTRY, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY FORM, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY FORM, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE INDUSTRY, 2025-2035 (USD Million)
  4. 7.2.4 BY FORM, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

North America Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

Electronics
Energy Storage
Composites
Coatings
Biomedicine

Pharmaceutical By Type (USD Million, 2025-2035)

Graphene Oxide
Reduced Graphene Oxide
Graphene Nanoplatelets
Monolayer Graphene

Pharmaceutical By End Use Industry (USD Million, 2025-2035)

Consumer Electronics
Automotive
Aerospace
Healthcare
Construction

Pharmaceutical By Form (USD Million, 2025-2035)

Powder
Suspension
Film
Dispersions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”